openPR Logo
Press release

Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study

04-25-2016 11:46 AM CET | Health & Medicine

Press release from: Bioquark Inc.

Bioquark Inc. and Revita Life Sciences Receive IRB Approval

Bioquark, Inc., (http://www.bioquark.com) a company focused on the development of novel biologics for complex regeneration and disease reversion, and Revita Life Sciences, (http://revitalife.co.in) a biotechnology company focused on translational therapeutic applications of autologous stem cells, have announced that they have received IRB approval for a study focusing on a novel combinatorial approach to clinical intervention in the state of brain death in humans.

This first trial, within the portfolio of Bioquark's Reanima Project (http://www.reanima.tech) is entitled “Non-randomized, Open-labeled, Interventional, Single Group, Proof of Concept Study With Multi-modality Approach in Cases of Brain Death Due to Traumatic Brain Injury Having Diffuse Axonal Injury” (https://clinicaltrials.gov/ct2/show/NCT02742857?term=bioquark&rank=1), will enroll an initial 20 subjects, and be conducted at Anupam Hospital in Rudrapur, Uttarakhand India.

“We are very excited about the approval of our protocol,” said Ira S. Pastor, CEO, Bioquark Inc. “With the convergence of the disciplines of regenerative biology, cognitive neuroscience, and clinical resuscitation, we are poised to delve into an area of scientific understanding previously inaccessible with existing technologies.”

Death is defined as the termination of all biological functions that sustain a living organism. Brain death, the complete and irreversible loss of brain function (including involuntary activity necessary to sustain life) as defined in the 1968 report of the Ad Hoc Committee of the Harvard Medical School, is the legal definition of human death in most countries around the world. Either directly through trauma, or indirectly through secondary disease indications, brain death is the final pathological state that over 60 million people globally transfer through each year.

While human beings lack substantial regenerative capabilities in the CNS, many non-human species, such as amphibians, planarians, and certain fish, can repair, regenerate and remodel substantial portions of their brain and brain stem even after critical life-threatening trauma.

Additionally, recent studies on complex brain regeneration in these organisms, have highlighted unique findings in relation to the storage of memories following destruction of the entire brain, which may have wide ranging implications for our understanding of consciousness and the stability of memory persistence.

“Through our study, we will gain unique insights into the state of human brain death, which will have important connections to future therapeutic development for other severe disorders of consciousness, such as coma, and the vegetative and minimally conscious states, as well as a range of degenerative CNS conditions, including Alzheimer's and Parkinson's disease,” said Dr. Sergei Paylian, Founder, President, and Chief Science Officer of Bioquark Inc.

Over the years, clinical science has focused heavily on preventing such life and death transitions and made some initial progress with suspended animation technologies, such as therapeutic hypothermia. However, once humans transition through the brain death window, currently defined by the medical establishment as “irreversible”, they are technically no longer alive, despite the fact that human bodies can still circulate blood, digest food, excrete waste, balance hormones, grow, sexually mature, heal wounds, spike a fever, and gestate and deliver a baby. It is even acknowledged by thought leaders that recently brain dead humans still may have residual blood flow and electrical nests of activity in their brains, just not enough to allow for an integrated functioning of the organism as a whole.

“We look forward to working closely with Bioquark Inc. on this cutting edge clinical initiative,” said Dr. Himanshu Bansal, Managing Director of Revita Life Sciences.

About Bioquark, Inc.

Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.

About Revita Life Sciences

Revita Life Sciences is a biotechnology company focused on the development of stem cell therapies that target areas of significant unmet medical need. Revita is led by Dr. Himanshu Bansal MD, PhD. who has spent over two decades developing novel MRI based classifications of spinal cord injuries as well as comprehensive treatment protocols with autologous tissues including bone marrow stem cells, dural nerve grafts, nasal olfactory tissues, and omental transposition.

Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.

1735 Market Street
Suite 3750
Phila, PA 19103
USA

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study here

News-ID: 335183 • Views:

More Releases from Bioquark Inc.

Bioquark Inc. and Ectocrine Technologies LLC to Collaborate on Mosquito-Derived …
Bioquark, Inc., an innovative life sciences company focused biotherapeutic development for human regeneration and disease reversion, and Ectocrine Technologies LLC, a biotech company dedicated to studying the positive human physiological effects of salivary secretions of hematophagous arthropods, such as mosquitos, of have announced a collaboration to focus on developing novel bio-products for human health and wellness. "We are very excited about this collaboration with Ectocrine Technologies," said Ira S. Pastor, CEO,

More Releases for Revita

RevitaNu Reviews: Anti-Aging Face Wrinkle Cream
Get RevitaNu For The Most Discounted Price >> https://rebrand.ly/lcbjhcq Skin problems are becoming more widespread. Human skin is extremely delicate and easily harmed. It's crucial to moisturize and nurture your skin as much as in winter. People should always wear sunscreen, and they should apply several layers of it to their face before leaving the house to shield their skin from the damaging UV rays and dust particles that can be
IV Hydration Therapy Market to Witness Stunning Growth to Generate Huge Revenue …
"IV Hydration Therapy Market" research report 2022-2030 provides a meticulous assessment of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. The IV Hydration Therapy report offers the latest study about the present global market development strategy, pre and posts covid-19 situation. It also gives a thorough overview of the market size based on end-user applications, products, types, trends and key regions. The IV
Europe IV Hydration Therapy Market Report Explores the Market Revenue status and …
The exclusive research report on 'Europe IV Hydration Therapy Market' now available with 𝐂𝐨𝐡𝐞𝐫𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, offers a detailed analysis of the factors influencing the global business sphere. This report also provides precise information pertaining to market size, commercialization aspects and revenue estimation of this business. The report further elucidates the status of leading industry players thriving in the competitive spectrum of the Europe IV Hydration Therapy Market. Hydration therapy is
Bioluma Anti Aging Cream Reviews: Price in US, UK, CANADA, Australia
Bioluma Anti Aging Cream Reviews: Price in US, UK, CANADA, Australia Bioluma Cream are obviously convenient to use. Each of its components is produced using natural added substances. Bioluma website Subsequently, it has no results. The elements of this cream are chosen after a colossal examination. An expert council was set up to find out his honesty. It does not contain compound or counterfeit substances. Click Here to Go Official Website: https://buzztimenews.com//bioluma-cream-order/ What
Shampoos For Hair Growth Market Demand Overview, Growth Innovation, Latest Trend …
The Shampoos For Hair Growth Market study inspects changing market trends, major segments, top investment pockets, value chain, competitive landscape, and regional scenario in great detail. The Shampoos For Hair Growth Market studies analyses growth rate, product price, profit, capacity, production, supply, demand, market growth rate, and forecast through 2027 for the world's major regions. The Shampoos For Hair Growth Market is expected to register a CAGR of 3.9% over the
Revitaa Pro NZ - Where to Buy Legitimate Revitaa Supplements in New Zealand?
Revista Pro NZ - Revitaa Pro is an ingenious and all-powerful weight loss supplement in New Zealand. It targets stress as a reason for weight gain, obesity, and related problems like raised glucose, and coronary illness. So, is Revitaa Pro a Legit weight loss supplement? To assist you with finding if it truly works, We have readied a fair review where you'll find the ingredients list, benefits, studies, side effects,